TIDMSHP TIDM0RN3
RNS Number : 3921M
D E Shaw & Co LP
07 January 2019
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: D. E. Shaw & Co., L.P.
(b) Owner or controller of interests and short positions disclosed, if
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s),
settlor and beneficiaries must be named.
--------------------------------------
(c) Name of offeror/offeree in relation to whose relevant securities this Takeda Pharmaceutical Company Limited
form relates:
Use a separate form for each offeror/offeree
--------------------------------------
(d) If an exempt fund manager connected with an offeror/offeree, state this
and specify identity
of offeror/offeree:
--------------------------------------
(e) Date position held/dealing undertaken: January 04, 2019
For an opening position disclosure, state the latest practicable date prior
to the disclosure
--------------------------------------
(f) In addition to the company in 1(c) above, is the discloser making Yes: Shire Plc
disclosures in respect
of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
--------------------------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant Ordinary: 15,200 share interests and 526,100 shares as short positions
security:
ADS (where one ADS = 0.5 ordinary shares): 2,650 equivalent shares as short positions
Interests Short positions
------------------------------------------- --------------------------------------------
Number % Number %
------------------------- --------------------------- ---------------
(1) Relevant securities
owned and/or controlled: 15,200 0.00 528,750 0.06
------------------------- ---------------- --------------------------- ---------------
(2) Cash-settled
derivatives: 58,600 0.00 7,528,000 0.95
------------------------- ---------------- --------------------------- ---------------
(3) Stock-settled
derivatives (including
options) and agreements
to purchase/sell: 436,000 0.05 436,000 0.05
------------------------- ---------------- --------------------------- ---------------
TOTAL: 509,800 0.06 8,492,750 1.08
------------------------- ---------------- --------------------------- ---------------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).;
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit
ADS Sale 2,500 USD 17.70
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,701.00
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,728.00
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,732.00
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,742.00
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,744.00
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,746.00
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,758.00
-------------- --------------------- ---------------
Ordinary Purchase 100 JPY 3,761.00
-------------- --------------------- ---------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the person making the disclosure and any party to the offer or
any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person
making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: January 07, 2019
Contact name: Kevin Krist (Compliance Department)
------------------------------------
Telephone number: +44 (0) 20 7409 4420
------------------------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION)
POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure: D. E. Shaw & Co., L.P.
Name of offeror/offeree in relation to whose relevant securities the Takeda Pharmaceutical Company Limited
disclosure relates:
--------------------------------------
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of Product Written or Number of Exercise price Type Expiry date
relevant description purchased securities to per unit e.g. American,
security e.g. call which option European etc.
option or derivative
relates
Ordinary OTC Call Purchased 104,700 JPY 5065.83 European 17/04/2019
Option
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Put Option Purchased -104,700 JPY 5065.83 European 17/04/2019
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Call Purchased 73,000 JPY 4455.61 European 07/05/2019
Option
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Put Option Purchased -73,000 JPY 4455.61 European 07/05/2019
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Call Purchased 68,400 JPY 4798 European 14/05/2019
Option
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Put Option Purchased -68,400 JPY 4798 European 14/05/2019
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Call Purchased 114,000 JPY 4750.02 European 14/05/2019
Option
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Put Option Purchased -114,000 JPY 4750.02 European 14/05/2019
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Call Purchased 75,900 JPY 4286.52 European 06/09/2019
Option
--------------- ---------------- --------------- ---------------- ---------------- ------------
Ordinary OTC Put Option Purchased -75,900 JPY 4286.52 European 06/09/2019
--------------- ---------------- --------------- ---------------- ---------------- ------------
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the
interest or position can be fully understood:
None
It is not necessary to provide details on a Supplemental Form
(Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be
stated.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RETLLFFLLAIDIIA
(END) Dow Jones Newswires
January 07, 2019 06:30 ET (11:30 GMT)
Shire (LSE:SHP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Shire (LSE:SHP)
Historical Stock Chart
From Jul 2023 to Jul 2024